Related Experiment Videos

Structural Analysis of The OXA-48 Carbapenemase Bound to A "Poor" Carbapenem Substrate, Doripenem

Krisztina M Papp-Wallace1,2,3, Vijay Kumar4, Elise T Zeiser5

  • 1Department of Biochemistry, Case Western Reserve University, Cleveland, OH 44106, USA. krisztina.papp@va.gov.

Insights

OXA-48 carbapenemase, a threat in healthcare, shows low activity against doripenem. Structural analysis reveals key residues V120 and Y211 influence doripenem binding and hydrolysis, guiding new antibiotic development.

Area of Science:

  • Microbiology
  • Structural Biology
  • Drug Discovery

Background:

  • Carbapenem-resistant Enterobacteriaceae (CRE) pose a significant global health threat.
  • OXA-48 carbapenemase is a major mechanism of carbapenem resistance.
  • The low hydrolytic activity of OXA-48 against doripenem remains mechanistically unclear.

Purpose of the Study:

  • To elucidate the structural basis for OXA-48's resistance to doripenem.
  • To identify key residues involved in OXA-48's interaction with doripenem.
  • To inform the design of novel carbapenem antibiotics less susceptible to OXA-48 hydrolysis.

Main Methods:

  • Determined the crystal structure of a deacylation-deficient OXA-48 variant (K73A) complexed with doripenem at 1.5 Å resolution.
  • Analyzed doripenem binding modes and interactions within the OXA-48 active site.
  • Compared doripenem interactions to those in previously studied OXA-carbapenem complexes.

Main Results:

  • Doripenem was observed covalently bound to the catalytic Ser70 residue in two tautomeric states.
  • Residue Y211's positioning reduced interactions of doripenem's carboxylate moiety with R250.
  • Residue V120 engaged in van der Waals interactions with doripenem's hydroxyethyl side chain, likely impacting deacylation.

Conclusions:

  • Residues V120 and Y211 are hypothesized to be critical for OXA-48's specific carbapenemase profile.
  • Structural insights provide a basis for developing carbapenem antibiotics resistant to OXA-48 hydrolysis.
  • Findings may guide the development of inhibitors targeting OXA carbapenemases.

Related Concept Videos